Skip to main content
Top
Published in: Infection 5/2018

01-10-2018 | Original Paper

Prevalence of, and risk factors for, hematogenous fungal endophthalmitis in patients with Candida bloodstream infection

Authors: Hideaki Kato, Yukihiro Yoshimura, Yoshihiro Suido, Kazuo Ide, Yoshifumi Sugiyama, Kasumi Matsuno, Hideaki Nakajima

Published in: Infection | Issue 5/2018

Login to get access

Abstract

Purpose

Endogenous fungal endophthalmitis (EFE) is a severe consequence of candidemia. The prevalence of, and risk factors for, EFE is not well studied.

Methods

We retrospectively collected cases of patients with candidemia who had undergone ophthalmological examination between April 2011 and March 2016 in five regional hospitals. We conducted bivariate and multivariate analyses using patients’ age, gender, causative Candida species, diabetes status, corticosteroid use, cancer status, neutropenia, intensive care unit admission, presence of central venous catheter (CVC), presence of shock, prior antibiotic use, 30-day mortality, and highest Sequential Organ Failure Assessment (SOFA) score. Data on sustained positive blood culture, β-d glucan, CVC removal, empirical antifungal drug used, and time to appropriate antifungal therapy were also collected if available.

Results

Of 174 patients with candidemia, 35 (20.1%) were diagnosed with EFE, including 31 (17.8%) with chorioretinitis and 4 (2.3%) with vitritis. Bivariate analysis (EFE group vs. non-EFE group) found that Candida albicans candidemia (77.1 vs. 34.5%, P < 0.001), neutropenia (14.3 vs. 5.8%, P = 0.141), CVC placement (94.3 vs. 71.2%, P = 0.004), and the presence of shock (28.6 vs. 16.5%, P = 0.145) were each higher in the EFE group. Multivariate logistic regression analysis found C. albicans candidemia (adjusted odds ratio 6.48; [95% CI 2.63–15.95]) and CVC placement (7.55 [1.56–36.53]) to be significant risk factors for EFE.

Conclusions

Candida albicans is the most common causative agent for Candida EFE. Patients with candidemia and CVC placement should be closely monitored by ophthalmologists.
Literature
2.
go back to reference Krishna R, Amuh D, Lowder C, Gordon S, Adal K, Hall G. Should all patients with candidaemia have an ophthalmic examination to rule out ocular candidiasis? Eye. 2000;14:30–4.CrossRefPubMed Krishna R, Amuh D, Lowder C, Gordon S, Adal K, Hall G. Should all patients with candidaemia have an ophthalmic examination to rule out ocular candidiasis? Eye. 2000;14:30–4.CrossRefPubMed
3.
go back to reference Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2015;62:e1–50.PubMedPubMedCentral Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2015;62:e1–50.PubMedPubMedCentral
4.
go back to reference Donahue S, Greven C, Zuravleff J, Eller A, Nguyen M, Peacock J, et al. Intraocular candidiasis in patients with candidemia. Clinical implications derived from a prospective multicenter study. Ophthalmology. 1994;101:1302–9.CrossRefPubMed Donahue S, Greven C, Zuravleff J, Eller A, Nguyen M, Peacock J, et al. Intraocular candidiasis in patients with candidemia. Clinical implications derived from a prospective multicenter study. Ophthalmology. 1994;101:1302–9.CrossRefPubMed
5.
go back to reference Henderson DK, Edwards JE, Montgomerie JZ. Hematogenous Candida endophthalmitis in patients receiving parenteral hyperalimentation fluids. J Infect Dis. 2014;143:655–61.CrossRef Henderson DK, Edwards JE, Montgomerie JZ. Hematogenous Candida endophthalmitis in patients receiving parenteral hyperalimentation fluids. J Infect Dis. 2014;143:655–61.CrossRef
6.
go back to reference Brooks RG. Prospective study of Candida endophthalmitis in hospitalized patients with candidemia. Arch Intern Med. 1989;149:2226–8.CrossRefPubMed Brooks RG. Prospective study of Candida endophthalmitis in hospitalized patients with candidemia. Arch Intern Med. 1989;149:2226–8.CrossRefPubMed
7.
go back to reference Geraymovych E, Conduff JH, Braich PS, Leffler CT, Brar VS. Prevalence and factors predictive of intraocular fungal infection in patients with fungemia at an academic urban tertiary care center. Clin Ophthalmol. 2015;9:1853–8.PubMedPubMedCentral Geraymovych E, Conduff JH, Braich PS, Leffler CT, Brar VS. Prevalence and factors predictive of intraocular fungal infection in patients with fungemia at an academic urban tertiary care center. Clin Ophthalmol. 2015;9:1853–8.PubMedPubMedCentral
8.
go back to reference Parke D, Jones D, Gentry L. Endogenous endophthalmitis among patients with candidemia. Ophthalmology. 1982;89:789–96.CrossRefPubMed Parke D, Jones D, Gentry L. Endogenous endophthalmitis among patients with candidemia. Ophthalmology. 1982;89:789–96.CrossRefPubMed
9.
go back to reference Kannangara S, Shindler D, Kunimoto DY, Sell B, DeSimone JA. Candidemia complicated by endophthalmitis: a prospective analysis. Eur J Clin Microbiol Infect Dis. 2007;26:839–41.CrossRefPubMed Kannangara S, Shindler D, Kunimoto DY, Sell B, DeSimone JA. Candidemia complicated by endophthalmitis: a prospective analysis. Eur J Clin Microbiol Infect Dis. 2007;26:839–41.CrossRefPubMed
10.
go back to reference Rodríguez-adrián LJ, King RT, Tamayo-derat LG, Miller JW, Garcia CA, Rex JH. Retinal lesions as clues to disseminated bacterial and candidal infections frequency, natural history, and etiology. Medicine (Baltimore). 2003;82:187–202. Rodríguez-adrián LJ, King RT, Tamayo-derat LG, Miller JW, Garcia CA, Rex JH. Retinal lesions as clues to disseminated bacterial and candidal infections frequency, natural history, and etiology. Medicine (Baltimore). 2003;82:187–202.
11.
go back to reference Oude Lashof AML, Rothova A, Sobel JD, Ruhnke M, Pappas PG, Viscoli C, et al. Ocular manifestations of candidemia. Clin Infect Dis. 2011;53:262–8.CrossRefPubMed Oude Lashof AML, Rothova A, Sobel JD, Ruhnke M, Pappas PG, Viscoli C, et al. Ocular manifestations of candidemia. Clin Infect Dis. 2011;53:262–8.CrossRefPubMed
12.
go back to reference Chen KJ, Wu WC, Sun MH, Lai CC, Chao AN. Endogenous fungal endophthalmitis: Causative organisms, management strategies, and visual acuity outcomes. Am J Ophthalmol. 2012;154:213–4.CrossRefPubMed Chen KJ, Wu WC, Sun MH, Lai CC, Chao AN. Endogenous fungal endophthalmitis: Causative organisms, management strategies, and visual acuity outcomes. Am J Ophthalmol. 2012;154:213–4.CrossRefPubMed
13.
go back to reference Diekema DJ, Messer SA, Brueggemann AB, Coffman SL, Doern GV, Herwaldt LA, et al. Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study. J Clin Microbiol. 2002;40:1298–302.CrossRefPubMedPubMedCentral Diekema DJ, Messer SA, Brueggemann AB, Coffman SL, Doern GV, Herwaldt LA, et al. Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study. J Clin Microbiol. 2002;40:1298–302.CrossRefPubMedPubMedCentral
14.
go back to reference McDonnell P, McDonnell J, Brown R, Green W. Ocular involvement in patients with fungal infections. Ophthalmology. 1985;92:706–9.CrossRefPubMed McDonnell P, McDonnell J, Brown R, Green W. Ocular involvement in patients with fungal infections. Ophthalmology. 1985;92:706–9.CrossRefPubMed
15.
go back to reference Schelenz S, Gransden WR. Candidaemia in a London teaching hospital: analysis of 128 cases over a 7-year period. Mycoses. 2003;46:390–6.CrossRefPubMed Schelenz S, Gransden WR. Candidaemia in a London teaching hospital: analysis of 128 cases over a 7-year period. Mycoses. 2003;46:390–6.CrossRefPubMed
16.
go back to reference Menezes A, Sigesmund DA, Demajo WA, Devenyi R. Mortality of hospitalized patients with Candida endophthalmitis. Arch Intern Med. 1994;154:2093–7.CrossRefPubMed Menezes A, Sigesmund DA, Demajo WA, Devenyi R. Mortality of hospitalized patients with Candida endophthalmitis. Arch Intern Med. 1994;154:2093–7.CrossRefPubMed
17.
go back to reference Stephen BY, Feman S, Nichols JC, Invitation BY, Chung SM, Invitation BY, et al. Endophthalmitis in patients with disseminated fungal disease. Trans Am Ophthalmol Soc. 2002;100:67–72. Stephen BY, Feman S, Nichols JC, Invitation BY, Chung SM, Invitation BY, et al. Endophthalmitis in patients with disseminated fungal disease. Trans Am Ophthalmol Soc. 2002;100:67–72.
18.
go back to reference Binder B, Chua J, Kaiser P, Procop G, Isada C. Endogenous endophthalmitis: an 18-year review of culture-positive cases at a tertiary care center. Medicine (Baltimore). 2003;82:97–105.CrossRef Binder B, Chua J, Kaiser P, Procop G, Isada C. Endogenous endophthalmitis: an 18-year review of culture-positive cases at a tertiary care center. Medicine (Baltimore). 2003;82:97–105.CrossRef
19.
go back to reference Raad I, Hanna H, Boktour M, Girgawy E, Danawi H, Mardani M, et al. Management of central venous catheters in patients with cancer and candidemia. Clin Infect Dis. 2004;38:1119–27.CrossRefPubMed Raad I, Hanna H, Boktour M, Girgawy E, Danawi H, Mardani M, et al. Management of central venous catheters in patients with cancer and candidemia. Clin Infect Dis. 2004;38:1119–27.CrossRefPubMed
20.
go back to reference Nucci M, Anaissie E, Betts RF, Dupont BF, Wu C, Buell DN, et al. Early removal of central venous catheter in patients with candidemia does not improve outcome: analysis of 842 patients from 2 randomized clinical trials. Clin Infect Dis. 2010;51:295–303.CrossRefPubMed Nucci M, Anaissie E, Betts RF, Dupont BF, Wu C, Buell DN, et al. Early removal of central venous catheter in patients with candidemia does not improve outcome: analysis of 842 patients from 2 randomized clinical trials. Clin Infect Dis. 2010;51:295–303.CrossRefPubMed
21.
go back to reference Farmakiotis D, Kyvernitakis A, Tarrand JJ, Kontoyiannis DP. Early initiation of appropriate treatment is associated with increased survival in cancer patients with Candida glabrata fungaemia: a potential benefit from infectious disease consultation. Clin Microbiol Infect. 2015;21:79–86.CrossRefPubMed Farmakiotis D, Kyvernitakis A, Tarrand JJ, Kontoyiannis DP. Early initiation of appropriate treatment is associated with increased survival in cancer patients with Candida glabrata fungaemia: a potential benefit from infectious disease consultation. Clin Microbiol Infect. 2015;21:79–86.CrossRefPubMed
22.
go back to reference Morrell M, Fraser VJ, Kollef MH. Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality delaying the empiric treatment of Candida bloodstream infection until positive blood culture. Antimicrob Agents Chemother. 2005;49:3640–5.CrossRefPubMedPubMedCentral Morrell M, Fraser VJ, Kollef MH. Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality delaying the empiric treatment of Candida bloodstream infection until positive blood culture. Antimicrob Agents Chemother. 2005;49:3640–5.CrossRefPubMedPubMedCentral
23.
go back to reference Zilberberg MD, Kollef MH, Arnold H, Labelle A, Micek ST, Kothari S, et al. Inappropriate empiric antifungal therapy for candidemia in the ICU and hospital resource utilization: a retrospective cohort study. BMC Infect Dis. 2010;10:150.CrossRefPubMedPubMedCentral Zilberberg MD, Kollef MH, Arnold H, Labelle A, Micek ST, Kothari S, et al. Inappropriate empiric antifungal therapy for candidemia in the ICU and hospital resource utilization: a retrospective cohort study. BMC Infect Dis. 2010;10:150.CrossRefPubMedPubMedCentral
24.
go back to reference Mochizuki K, Sawada A, Suemori S, Kawakami H, Niwa Y, Kondo Y, et al. Intraocular penetration of intravenous micafungin in inflamed human eyes. Antimicrob Agents Chemother. 2013;57:4027–30.CrossRefPubMedPubMedCentral Mochizuki K, Sawada A, Suemori S, Kawakami H, Niwa Y, Kondo Y, et al. Intraocular penetration of intravenous micafungin in inflamed human eyes. Antimicrob Agents Chemother. 2013;57:4027–30.CrossRefPubMedPubMedCentral
25.
go back to reference Riddell IVJ, Comer GM, Kauffman CA. Treatment of endogenous fungal endophthalmitis: focus on new antifungal agents. Clin Infect Dis. 2011;52:648–53.CrossRefPubMed Riddell IVJ, Comer GM, Kauffman CA. Treatment of endogenous fungal endophthalmitis: focus on new antifungal agents. Clin Infect Dis. 2011;52:648–53.CrossRefPubMed
26.
go back to reference Hariprasad SM, Mieler WF, Holz ER, Gao H, Kim JE, Chi J, et al. Determination of vitreous, aqueous, and plasma concentration of orally administered voriconazole in humans. Arch Ophthalmol. 2004;122:42–7.CrossRefPubMed Hariprasad SM, Mieler WF, Holz ER, Gao H, Kim JE, Chi J, et al. Determination of vitreous, aqueous, and plasma concentration of orally administered voriconazole in humans. Arch Ophthalmol. 2004;122:42–7.CrossRefPubMed
27.
go back to reference Blennow O, Tallstedt L, Hedquist B, Gårdlund B. Duration of treatment for candidemia and risk for late-onset ocular candidiasis. Infection. 2013;41:129–34.CrossRefPubMed Blennow O, Tallstedt L, Hedquist B, Gårdlund B. Duration of treatment for candidemia and risk for late-onset ocular candidiasis. Infection. 2013;41:129–34.CrossRefPubMed
Metadata
Title
Prevalence of, and risk factors for, hematogenous fungal endophthalmitis in patients with Candida bloodstream infection
Authors
Hideaki Kato
Yukihiro Yoshimura
Yoshihiro Suido
Kazuo Ide
Yoshifumi Sugiyama
Kasumi Matsuno
Hideaki Nakajima
Publication date
01-10-2018
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 5/2018
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-018-1163-z

Other articles of this Issue 5/2018

Infection 5/2018 Go to the issue